INTEGRIA, UAB - financials and debts

Company age: 22 y. 2 mo.

Update

INTEGRIA - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 4,349,063 5,880,663 5,327,307 2,963,738 5,862,226 6,065,879 6,532,975 5,396,297
Profit before tax 52,745 196,071 45,569 36,868 204,687 238,810 117,337 135,779
Net profit 44,528 166,563 38,675 31,248 173,812 202,988 99,552 113,866
Equity 604,549 711,112 499,787 471,036 644,848 729,836 711,388 825,254
Liabilities 572,482 331,233 275,553 242,965 544,959 473,443 529,644 452,162
Non-current assets 8,347 6,703 1,620 2,255 2,215 4,486 7,550 4,310
Current assets 1,169,514 1,036,910 775,060 719,117 1,189,716 1,203,555 1,231,589 1,271,214
Total assets 1,177,861 1,043,613 776,680 721,372 1,191,931 1,208,041 1,239,139 1,275,524
Taxes paid
STI taxes - - - - - 319,420 261,611 202,093
Social insurance contributions - - - - - 24,203 32,828 32,158
Financial indicators
Revenue change y/y -19.7% +35.2% -9.4% -44.4% +97.8% +3.5% +7.7% -17.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 3.8% 16.0% 5.0% 4.3% 14.6% 16.8% 8.0% 8.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 7.4% 23.4% 7.7% 6.6% 27.0% 27.8% 14.0% 13.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 1.0% 2.8% 0.7% 1.1% 3.0% 3.3% 1.5% 2.1%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 1.2% 3.3% 0.9% 1.2% 3.5% 3.9% 1.8% 2.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.9 0.5 0.6 0.5 0.8 0.6 0.7 0.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 573,505 953,616 887,885 493,956 977,038 1,010,980 922,307 761,834

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

INTEGRIA - Social security debts

From To Debt, €
2026-05-17 2026-05-20 40.32
2023-05-16 2023-05-17 42.37
2022-05-17 2022-05-18 18.27

INTEGRIA - VMI tax arrears

From To Overdue, €
2025-09-28 2025-09-29 43.87
2025-03-02 2025-03-06 6.13
2025-02-28 2025-03-01 2.53
2025-02-23 2025-02-25 644.17
2025-02-19 2025-02-22 1.17
2025-02-02 2025-02-10 86.72
2025-01-31 2025-02-01 10.97
2024-12-19 2025-01-01 6.69
2024-12-03 2024-12-12 6.69
2024-11-17 2024-11-18 1292.81

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
INTEGRIA, UAB (code 300040802) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €5.40M and net profit of €113.9K, with a profit margin of 2.1%. Revenue decreased by 17.4% year on year in 2025 and was 11.0% lower than two years earlier, following €6.53M in 2024 and €6.07M in 2023. Profitability was weaker in 2024, when net profit fell to €99.6K, before improving in 2025. The balance sheet remained stable, with total assets of €1.28M at year-end 2025, compared with €1.24M in 2024 and €1.21M in 2023. Equity increased to €825.3K in 2025, while liabilities stood at €452.2K. Key ratios for 2025 show a return on equity of 13.8%, return on assets of 8.9%, a debt-to-equity ratio of 0.55, and asset turnover of 4.23x. Revenue per employee was €770.9K, indicating strong operating productivity.